Bioinformatics

Global Bioinformatics Market to Reach US$45.2 Billion by 2030

The global market for Bioinformatics estimated at US$20.9 Billion in the year 2024, is expected to reach US$45.2 Billion by 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Knowledge Management Tools, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$18.8 Billion by the end of the analysis period. Growth in the Bioinformatics Platforms segment is estimated at 15.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 17.9% CAGR

The Bioinformatics market in the U.S. is estimated at US$5.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Global Bioinformatics Market - Key Trends and Drivers Summarized

What Is Bioinformatics and How Is It Transforming Biological Sciences?

Bioinformatics is an interdisciplinary field that merges biology, computer science, and information technology to analyze and interpret biological data. It emerged as a crucial discipline following the human genome project, which generated vast amounts of data, necessitating sophisticated computational techniques to make sense of it all. Bioinformatics tools and methodologies are used to manage and analyze genetic and genomic information, facilitating significant advancements in areas such as personalized medicine, drug discovery, and genetic research. This field leverages computational modeling, data mining, and algorithm development to predict interactions between molecules, identify genetic mutations, and understand complex biological processes. The application of bioinformatics extends beyond genomics to proteomics, metabolomics, and other bioinformatics-driven fields, making it an essential pillar in modern biological and medical research.

How Are Technological Advancements Shaping Bioinformatics?

Technological advancements are dramatically shaping the field of bioinformatics, enhancing its capacity to process and analyze increasingly large datasets. The advent of next-generation sequencing (NGS) technologies has decreased the cost and increased the speed and accuracy of genetic analysis, generating unprecedented amounts of data. In response, bioinformatics has adapted through the development of more powerful computational tools and sophisticated algorithms capable of handling massive datasets — commonly referred to as `big data.` Cloud computing has also become integral, providing the necessary infrastructure to store and analyze large data sets efficiently and cost-effectively. Additionally, artificial intelligence (AI) and machine learning (ML) are increasingly integrated into bioinformatics workflows, improving the ability to discern patterns and make predictions from complex biological data, which is crucial for advancements in fields like genomics and epidemiology.

What Role Does Bioinformatics Play in Healthcare and Pharmaceutical Industries?

In the healthcare and pharmaceutical industries, bioinformatics is playing a pivotal role in driving innovations and improving outcomes. In drug discovery and development, bioinformatics tools are used to model biological processes and improve the understanding of disease mechanisms, which can lead to the identification of new therapeutic targets. It also facilitates the design and development of new drugs by simulating their interactions with biological molecules, greatly reducing the need for early-stage clinical trials. Furthermore, bioinformatics is integral to the field of precision medicine, as it allows for the analysis of patient-specific data to tailor treatments to individual genetic profiles. This not only improves the effectiveness of treatments but also minimizes adverse drug reactions, paving the way for more personalized healthcare solutions.

What Drives the Growth in the Bioinformatics Market?

The growth in the bioinformatics market is driven by several factors, reflecting the expanding scope and application of this field. The increasing demand for nucleic acid and protein sequencing and the rising prevalence of chronic diseases requiring complex genomic study are significant growth drivers. Technological advancements that provide enhanced data storage solutions and improved computational speeds also contribute to the expansion of bioinformatics. Additionally, the growing application of bioinformatics in drug discovery processes and personalized medicine is fueling demand across the pharmaceutical and biotechnology sectors. Government and private funding for research in genomics and post-genomics is another critical factor, as is the growing use of bioinformatics in agriculture for crop improvement and pest resistance. The increasing incorporation of AI and ML technologies into bioinformatics tools is not only enhancing efficiencies but also opening new avenues for innovation and market growth. These factors, combined with the ongoing need to manage and interpret the vast amounts of data generated by modern biological and medical research, ensure a dynamic and rapidly evolving bioinformatics market.

SCOPE OF STUDY:

The report analyzes the Bioinformatics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product & Service (Knowledge Management Tools, Bioinformatics Platforms, Bioinformatics Services); Sector (Medical Biotechnology, Agricultural Biotechnology, Animal Biotechnology, Environmental Biotechnology, Forensic Biotechnology, Other Sectors); Application (Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, Other Applications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 102 Featured) -

• Agilent Technologies, Inc.
• Dassault Systèmes
• ID Business Solutions Ltd.
• Illumina Inc.
• Instem plc
• Kinexus Bioinformatics Corporation
• Life Technologies
• Nonlinear Dynamics Ltd.
• Ocimum Biosolutions Ltd.
• PerkinElmer Inc.
• QIAGEN N.V.
• Strand Life Sciences
• Thermo Fischer Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.